8.83

1.23% -0.11

Adicet Bio Inc (ACET)

Overview News Price History Option Chain Financials Discussions Forecast

Adicet Bio Inc stock is traded at $8.83, with a volume of 60,798. It is down -1.23% in the last 24 hours and up +20.79% over the past month. Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Previous Close:

$8.94

Open:

$8.95

24h Volume:

60,798

Relative Volume:

0.54

Market Cap:

$82.54M

Revenue:

$24.99M

Net Income/Loss:

$-108.83M

P/E Ratio:

-0.5875

EPS:

-15.0286

Net Cash Flow:

$-91.62M

1W Performance:

-1.89%

1M Performance:

+20.79%

6M Performance:

+9.96%

1Y Performance:

-25.40%

1-Day Range:

$8.675

$8.98

1-Week Range:

$8.49

$9.42

52-Week Range:

$6.01

$17.44

Adicet Bio Inc Stock (ACET) Company Profile

Name

Adicet Bio Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

617-482-2333

Address

131 DARTMOUTH STREET, BOSTON

Employee

102

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

ACET's Discussions on Twitter

Compare ACET vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACET Adicet Bio Inc	8.83	82.54M	24.99M	-108.83M	-91.62M	-15.03
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-24	Resumed	Guggenheim	Buy
Sep-11-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral
Sep-21-22	Initiated	JP Morgan	Overweight
Mar-31-22	Initiated	SMBC Nikko	Outperform
Mar-08-22	Initiated	Truist	Buy
Mar-04-22	Initiated	Jefferies	Buy
May-18-21	Initiated	BTIG Research	Buy
Apr-23-21	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Canaccord Genuity	Buy
Apr-08-21	Initiated	Guggenheim	Buy
Nov-04-20	Initiated	B. Riley Securities	Buy
Oct-27-20	Initiated	JMP Securities	Mkt Outperform
Oct-16-20	Initiated	Wedbush	Outperform

View All

Adicet Bio Inc Stock (ACET) Latest News

Jul 11, 2026

Price to earnings forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Jul 11, 2026

Enterprise value to revenue forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Jul 11, 2026

Jul 09, 2026

Adicet Bio (ACET) Proxy filing Summary - Quartr

Jul 09, 2026

Are medical stocks lagging Adicet Bio (ACET) this year? - MSN

Jul 09, 2026

Jul 07, 2026